These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 38277021)

  • 1. Anakinra in idiopathic recurrent pericarditis: a comprehensive case series and literature review.
    Toker Dincer Z; Karup S; Yilmaz E; Corbali O; Azman FN; Melikoglu M; Ugurlu S
    Z Rheumatol; 2024 Sep; 83(7):587-596. PubMed ID: 38277021
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anakinra in idiopathic recurrent pericarditis refractory to immunosuppressive therapy; a preliminary experience in seven patients.
    Dagan A; Langevitz P; Shoenfeld Y; Shovman O
    Autoimmun Rev; 2019 Jun; 18(6):627-631. PubMed ID: 30959216
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of an interleukin-1β receptor antagonist (anakinra) in idiopathic recurrent pericarditis.
    Scardapane A; Brucato A; Chiarelli F; Breda L
    Pediatr Cardiol; 2013; 34(8):1989-91. PubMed ID: 23052671
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of anakinra for idiopathic and non-idiopathic pericarditis refractory or intolerant to conventional therapy.
    Shaukat MH; Singh S; Davis K; Torosoff M; Peredo-Wende R
    Eur Heart J Acute Cardiovasc Care; 2020 Dec; 9(8):888-892. PubMed ID: 32159368
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Successful treatment of idiopathic recurrent pericarditis in children with interleukin-1beta receptor antagonist (anakinra): an unrecognized autoinflammatory disease?
    Picco P; Brisca G; Traverso F; Loy A; Gattorno M; Martini A
    Arthritis Rheum; 2009 Jan; 60(1):264-8. PubMed ID: 19116906
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anakinra effectiveness in refractory polyserositis: An Italian multicenter study.
    Lopalco G; Venerito V; Brucato A; Emmi G; Giacomelli R; Cauli A; Piga M; Parronchi P; Nivuori M; Malandrino D; Ruscitti P; Vitiello G; Fabiani C; Cantarini L; Iannone F
    Joint Bone Spine; 2022 Mar; 89(2):105299. PubMed ID: 34656754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness and Safety of Anakinra for Management of Refractory Pericarditis.
    Jain S; Thongprayoon C; Espinosa RE; Hayes SN; Klarich KW; Cooper LT; Moder KG; Anavekar NS; Oh JK; Matteson EL
    Am J Cardiol; 2015 Oct; 116(8):1277-9. PubMed ID: 26279106
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of idiopathic recurrent pericarditis in adults and in children: a role for IL-1 receptor antagonism.
    Brucato A; Emmi G; Cantarini L; Di Lenarda A; Gattorno M; Lopalco G; Marcolongo R; Imazio M; Martini A; Prisco D
    Intern Emerg Med; 2018 Jun; 13(4):475-489. PubMed ID: 29633070
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Failure of anti Interleukin-1 β monoclonal antibody in the treatment of recurrent pericarditis in two children.
    Signa S; D'Alessandro M; Consolini R; Miniaci A; Bustaffa M; Longo C; Tosca MA; Bizzi M; Caorsi R; Mendonça LO; Pession A; Ravelli A; Gattorno M
    Pediatr Rheumatol Online J; 2020 Jun; 18(1):51. PubMed ID: 32546242
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autoinflammatory Recurrent Pericarditis Associated with a New NLRP12 Mutation in a Male Adolescent.
    Cinteza E; Stefan D; Iancu MA; Ioan A; Vasile CM; Vatasescu R; Cochino A
    Life (Basel); 2023 Oct; 13(11):. PubMed ID: 38004271
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pericarditis and Autoinflammation: A Clinical and Genetic Analysis of Patients With Idiopathic Recurrent Pericarditis and Monogenic Autoinflammatory Diseases at a National Referral Center.
    Peet CJ; Rowczenio D; Omoyinmi E; Papadopoulou C; Mapalo BRR; Wood MR; Capon F; Lachmann HJ
    J Am Heart Assoc; 2022 Jun; 11(11):e024931. PubMed ID: 35658515
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Idiopathic recurrent pericarditis refractory to colchicine treatment can reveal tumor necrosis factor receptor-associated periodic syndrome.
    Cantarini L; Lucherini OM; Cimaz R; Baldari CT; Bellisai F; Rossi Paccani S; Laghi Pasini F; Capecchi PL; Sebastiani GD; Galeazzi M
    Int J Immunopathol Pharmacol; 2009; 22(4):1051-8. PubMed ID: 20074469
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anakinra for corticosteroid-dependent and colchicine-resistant pericarditis: The IRAP (International Registry of Anakinra for Pericarditis) study.
    Imazio M; Andreis A; De Ferrari GM; Cremer PC; Mardigyan V; Maestroni S; Luis SA; Lopalco G; Emmi G; Lotan D; Marcolongo R; Lazaros G; De Biasio M; Cantarini L; Dagna L; Cercek AC; Pivetta E; Varma B; Berkson L; Tombetti E; Iannone F; Prisco D; Caforio ALP; Vassilopoulos D; Tousoulis D; De Luca G; Giustetto C; Rinaldi M; Oh JK; Klein AL; Brucato A; Adler Y
    Eur J Prev Cardiol; 2020 Jun; 27(9):956-964. PubMed ID: 31610707
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term efficacy of interleukin-1 receptor antagonist (anakinra) in corticosteroid-dependent and colchicine-resistant recurrent pericarditis.
    Finetti M; Insalaco A; Cantarini L; Meini A; Breda L; Alessio M; D'Alessandro M; Picco P; Martini A; Gattorno M
    J Pediatr; 2014 Jun; 164(6):1425-31.e1. PubMed ID: 24630353
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anakinra for the management of resistant idiopathic recurrent pericarditis. Initial experience in 10 adult cases.
    Lazaros G; Vasileiou P; Koutsianas C; Antonatou K; Stefanadis C; Pectasides D; Vassilopoulos D
    Ann Rheum Dis; 2014 Dec; 73(12):2215-7. PubMed ID: 25165036
    [No Abstract]   [Full Text] [Related]  

  • 16. Anaphylactic reaction to anakinra in a child with steroid-dependent idiopathic recurrent pericarditis and successful management with canakinumab.
    Epçaçan S; Sahin S; Kasapcopur O
    Cardiol Young; 2019 Apr; 29(4):549-551. PubMed ID: 30931868
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel therapy for an unusual problem: IL-1 receptor antagonist for recurrent post-transplant pericarditis.
    Parizo JT; Moayedi Y; Nieman K; Town K; Teuteberg JJ; Khush KK
    Clin Transplant; 2019 Oct; 33(10):e13699. PubMed ID: 31437316
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The autoinflammatory side of recurrent pericarditis: Enlightening the pathogenesis for a more rational treatment.
    Lopalco G; Rigante D; Cantarini L; Imazio M; Lopalco A; Emmi G; Venerito V; Fornaro M; Frediani B; Nivuori M; Brucato A; Iannone F
    Trends Cardiovasc Med; 2021 Jul; 31(5):265-274. PubMed ID: 32376492
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of colchicine in addition to anakinra in patients with recurrent pericarditis.
    Collini V; Andreis A; De Biasio M; De Martino M; Isola M; Croatto N; Lepre V; Cantarini L; Merlo M; Sinagra G; Abbate A; Lazaros G; Brucato A; Klein AL; Imazio M
    Open Heart; 2024 Mar; 11(1):. PubMed ID: 38490715
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of anakinra in an adult patient with recurrent pericarditis and cardiac tamponade as initial manifestations of tumor necrosis factor receptor-associated periodic syndrome due to the R92Q TNFRSF1A variant.
    Camprubí D; Mitjavila F; Arostegui JI; Corbella X
    Int J Rheum Dis; 2017 Apr; 20(4):510-514. PubMed ID: 27990755
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.